NFA
HBIO icon

Nationwide Fund Advisors’s Harvard Bioscience HBIO Stock Holding History

Nationwide Fund Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-887
Closed -$33K – 890
2017
Q3 		$33K Hold
887
– – ﹤0.01% 3078
2017
Q2 		$23K Hold
887
– – ﹤0.01% 3104
2017
Q1 		$23K Hold
887
– – ﹤0.01% 3076
2016
Q4 		$27K Hold
887
– – ﹤0.01% 3064
2016
Q3 		$24K Hold
887
– – ﹤0.01% 3111
2016
Q2 		$25K Sell
887
-2,131
-71% -$67.8K ﹤0.01% 3140
2016
Q1 		$91K Hold
3,018
– – ﹤0.01% 2861
2015
Q4 		$105K Buy
3,018
+129
+4% +$4.41K ﹤0.01% 2825
2015
Q3 		$109K Hold
2,889
– – ﹤0.01% 2864
2015
Q2 		$165K Buy
2,889
+2,002
+226% +$114K ﹤0.01% 2801
2015
Q1 		$52K Hold
887
– – ﹤0.01% 3091
2014
Q4 		$50K Hold
887
– – ﹤0.01% 3023
2014
Q3 		$36K Hold
887
– – ﹤0.01% 3127
2014
Q2 		$40K Sell
887
-1,990
-69% -$83.6K ﹤0.01% 3111
2014
Q1 		$136K Buy
2,877
+43
+2% +$1.96K ﹤0.01% 2644
2013
Q4 		$133K Sell
2,834
-626
-18% -$27.3K ﹤0.01% 2852
2013
Q3 		$138K Buy
3,460
+413
+14% +$16.2K ﹤0.01% 2841
2013
Q2 		$109K Buy
+3,047
New +$117K ﹤0.01% 2769

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPC
Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Nationwide Fund Advisors's HBIO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Harvard Bioscience (HBIO) in Q4 2017, closing a stake of 887 shares — an estimated $33K sold.

Nationwide Fund Advisors first reported a position in HBIO in Q2 2013 and held it in 18 quarters. The position peaked at $165K in Q2 2015. 55 funds tracked by Wall St. Rank hold HBIO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Harvard Bioscience position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 887 Harvard Bioscience shares in Q4 2017, an estimated $33K.
  • Nationwide Fund Advisors first reported a position in Harvard Bioscience in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Harvard Bioscience position peaked at $165K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.